CVATCVATOTC
Loading
Year-over-year research & development expense growth
Latest
-42.86%
↓ 172% vs avg
Percentile
P31
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
59.21%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -42.86% |
| Q3 2025 | -75.86% |
| Q2 2025 | -30.95% |
| Q1 2025 | 162.50% |
| Q4 2024 | 100.00% |
| Q3 2024 | -50.00% |
| Q2 2024 | 77.78% |
| Q1 2024 | 0.00% |
| Q4 2023 | -100.00% |
| Q3 2023 | 1100.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | -100.00% |
| Q2 2022 | -92.86% |
| Q1 2022 | 600.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | -100.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | -100.00% |
| Q4 2020 | -16.67% |
| Q3 2020 | -25.00% |
| Q2 2020 | 100.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 100.00% |
| Q3 2019 | -50.00% |
| Q2 2019 | -63.64% |
| Q1 2019 | 83.33% |
| Q4 2018 | 200.00% |
| Q3 2018 | -83.33% |
| Q2 2018 | 200.00% |
| Q1 2018 | -23.74% |
| Q4 2017 | 83.65% |
| Q3 2017 | -77.21% |
| Q2 2017 | 81.77% |
| Q1 2017 | 410.29% |
| Q4 2016 | -78.65% |
| Q3 2016 | -36.97% |
| Q2 2016 | 123.03% |
| Q1 2016 | 93.97% |